Merck & Co to Acquire Imago BioSciences for $1.35 Billion
On Monday, Merck & Co Inc said it would acquire Imago BioSciences Inc, the cancer drug developer, for a total equity value of USD 1.35...
Download Unicorn Signals App
Powered By EquityPandit
